Skip to content

Counseling During Pulmonary Rehabilitation

Effect of Counseling During Pulmonary Rehabilitation on Self-determined Motivation Towards Physical Activity in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02455206
Enrollment
43
Registered
2015-05-27
Start date
2015-10-31
Completion date
2020-02-29
Last updated
2021-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The purpose of this study is to investigate if a physical activity counseling program during pulmonary rehabilitation increases the physical activity level in daily life in patients with Chronic Obstructive Pulmonary Disease.

Detailed description

Participants performed a 12 weeks outpatient pulmonary rehab (PR) according to guidelines. Participants allocated to intervention received PR plus physical activity (PA) counselling. PA counselling was performed using motivational interviewing techniques and was provided by two experiences physiotherapists independant to the rehab team. After PR and three months follow-up was evaluated if PA counselling during PR increases PA elvel (primary outcome: steps per day) in daily life. Furthermore, individual, semi-structured interviews were performed in a subgroup of participants in order to gain more detailed information about barriers and enablers of participation in daily-life activities. Participants were invited to two interviews, one right after PR the other after 3 months follow up. A content analysis was performed.

Interventions

BEHAVIORALphysical activity counseling

5 face-to-face sessions a 30 minutes during 12 weeks pulmonary rehabilitation program.

BEHAVIORALUsual care

Sponsors

Kantonsspital Winterthur KSW
CollaboratorOTHER
Schweizer Lungenliga
CollaboratorUNKNOWN
Zurich University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* confirmed COPD (GOLD stages B-D) according to GOLD-guidelines

Exclusion criteria

* Mental or physical disability (mini-mental score \<20) precluding informed consent or compliance with the protocol * morphine medication * Primary diagnosis of heart failure * Uncontrolled arrhythmias causing symptoms or hemodynamic compromise * Severe co-morbidity (acute coronary syndrome, unstable angina terminal renal failure, concomitant pulmonary embolism, very severe pneumonia: CURB65\>3) * Severe untreated arterial hypertension at rest (\> 200 mm Hg systolic, \> 120 mm Hg diastolic)

Design outcomes

Primary

MeasureTime frame
number of steps per day6 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026